Long-term proton pump inhibitor therapy: is IT really safe? a narrative review
Abstract
Background: Proton pump inhibitors (PPIs) are among the most commonly prescribed medications worldwide and remain the cornerstone of treatment for acid-related gastrointestinal disorders. Despite their effectiveness and good safety profile, concerns have arisen regarding overuse and potential long-term adverse effects. Aim: This review assessed the safety of long-term PPI therapy, summarized current evidence on adverse effects and addressed common misconceptions. Material and methods: A narrative review of PubMed/MEDLINE and Google Scholar literature (2020–2026) was conducted, including key earlier studies. Priority was given to systematic reviews, meta-analyses, randomized trials and guidelines from ACG, AGA, NICE, FDA, and EMA. Results: Long-term PPI use has been linked to vitamin B12 and iron deficiency, fractures, chronic kidney disease, Clostridioides difficile infection and possible cognitive impairment. However, most data are observational, and causality is unproven. Higher risk occurs in older adults, patients with comorbidities and those on prolonged high-dose therapy. Inappropriate prescribing and prolonged treatment without clear indications remain significant clinical concerns. Conclusions: PPIs are effective and generally safe when used appropriately. Potential risks should not limit their use when indicated. Therapy should be individualized, regularly reassessed and use the lowest effective dose for the shortest duration.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.